Suppr超能文献

围手术期给予甲泼尼龙与老年髋部骨折手术患者术后肺部并发症相关。

Perioperative administration of methylprednisolone was associated with postoperative pulmonary complications in elderly patients undergoing hip fracture surgery.

作者信息

Zhou Jun, Chen Chaojin, Cheng Nan, Xing Jibin, Guo Rongchang, Li Lusi, Yang Dong, Hei Ziqing, Zhou Shaoli

机构信息

Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Guangzhou, 510630, China.

Guangzhou AID Cloud Technology Co., LTD, Guangzhou, 510000, China.

出版信息

Aging Clin Exp Res. 2022 Sep;34(9):2005-2012. doi: 10.1007/s40520-022-02166-0. Epub 2022 Aug 4.

Abstract

BACKGROUND

Postoperative pulmonary complications (PPCs) seriously affect the postoperative prognosis of elderly patients underwent hip fracture surgery. Although methylprednisolone is increasingly used, the association between perioperative methylprednisolone and PPCs is still controversial. The study aims to determine whether perioperative administration of methylprednisolone is associated with PPCs in elderly patients during hip fracture surgery.

PATIENTS AND METHODS

In this retrospective cohort study, records of 584 patients (≥ 65 years) who underwent hip fracture surgery between January 2013 and October 2020 were extracted. Univariate and multivariate regression analysis were performed to identify the risk factors for PPCs. To further explore the association between administration of methylprednisolone and PPCs, 53 patients received methylprednisolone and 53 patients without methylprednisolone were matched for the confounding factors using propensity score matching (PSM) analysis. The odds ratios (OR) and 95% confidence intervals (CI) for the above variables were analyzed.

RESULTS

The incidence of PPCs during postoperative hospitalization was 6.83% (38/556) among the elderly patients following hip fracture surgery. Patients with PPCs had higher postoperative mortality rate, longer hospital stay, more hospitalization cost, and higher incidence of cardiac arrest (all P < 0.05). Multivariate logistic regression analysis showed that age, hypertension, hypoglycemia, hypoproteinemia and perioperative methylprednisolone were independent risk factors for PPCs. Moreover, administration of methylprednisolone was significantly correlated with PPCs both before PSM adjustment (OR = 3.25; 95% CI, 1.67 to 6.33; P = 0.001) and after PSM adjustment (OR = 6.68; 95% CI, 1.40 to 31.82; P = 0.017).

CONCLUSION

Perioperative administration of methylprednisolone is a risk factor for PPCs in elderly patients undergoing hip fracture surgery.

摘要

背景

术后肺部并发症(PPCs)严重影响接受髋部骨折手术的老年患者的术后预后。尽管甲基泼尼松龙的使用越来越多,但围手术期使用甲基泼尼松龙与PPCs之间的关联仍存在争议。本研究旨在确定围手术期给予甲基泼尼松龙是否与老年髋部骨折手术患者的PPCs相关。

患者与方法

在这项回顾性队列研究中,提取了2013年1月至2020年10月期间接受髋部骨折手术的584例(≥65岁)患者的记录。进行单因素和多因素回归分析以确定PPCs的危险因素。为进一步探讨甲基泼尼松龙的使用与PPCs之间的关联,采用倾向评分匹配(PSM)分析对53例接受甲基泼尼松龙治疗的患者和53例未接受甲基泼尼松龙治疗的患者进行混杂因素匹配。分析上述变量的比值比(OR)和95%置信区间(CI)。

结果

髋部骨折手术后老年患者术后住院期间PPCs的发生率为6.83%(38/556)。发生PPCs的患者术后死亡率更高、住院时间更长、住院费用更多且心脏骤停发生率更高(均P<0.05)。多因素逻辑回归分析显示,年龄、高血压、低血糖、低蛋白血症和围手术期使用甲基泼尼松龙是PPCs的独立危险因素。此外,在PSM调整前(OR=3.25;95%CI,1.67至6.33;P=0.001)和PSM调整后(OR=6.68;95%CI,1.40至31.82;P=0.017),甲基泼尼松龙的使用均与PPCs显著相关。

结论

围手术期给予甲基泼尼松龙是老年髋部骨折手术患者发生PPCs的危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验